Please use this identifier to cite or link to this item: https://doi.org/10.1186/s13287-021-02648-4
Title: Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells
Authors: Tang, Shin Yi 
Zha, Shijun 
Du, Zhicheng 
Zeng, Jieming
Zhu, Detu
Luo, Yumei
Wang, Shu 
Keywords: Adeno-associated virus integration site 1 (AAVS1)
Chimeric antigen receptors (CAR)
Epithelial cell adhesion molecule (EpCAM)
Genetic engineering
Immunotherapy
Induced pluripotent stem cells (iPSC)
Natural killer cells (NK)
NK differentiation
Targeted integration
Zinc finger nuclease (ZFN)
Issue Date: 21-Nov-2021
Publisher: BioMed Central Ltd
Citation: Tang, Shin Yi, Zha, Shijun, Du, Zhicheng, Zeng, Jieming, Zhu, Detu, Luo, Yumei, Wang, Shu (2021-11-21). Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells. Stem Cell Research and Therapy 12 (1) : 580. ScholarBank@NUS Repository. https://doi.org/10.1186/s13287-021-02648-4
Rights: Attribution 4.0 International
Abstract: Background: Redirection of natural killer (NK) cells with chimeric antigen receptors (CAR) is attractive in developing off-the-shelf CAR therapeutics for cancer treatment. However, the site-specific integration of a CAR gene into NK cells remains challenging. Methods: In the present study, we genetically modified human induced pluripotent stem cells (iPSCs) with a zinc finger nuclease (ZFN) technology to introduce a cDNA encoding an anti-EpCAM CAR into the adeno-associated virus integration site 1, a “safe harbour” for transgene insertion into human genome, and next differentiated the modified iPSCs into CAR-expressing iNK cells. Results: We detected the targeted integration in 4 out of 5 selected iPSC clones, 3 of which were biallelically modified. Southern blotting analysis revealed no random integration events. iNK cells were successfully derived from the modified iPSCs with a 47-day protocol, which were morphologically similar to peripheral blood NK cells, displayed NK phenotype (CD56+CD3-), and expressed NK receptors. The CAR expression of the iPSC-derived NK cells was confirmed with RT-PCR and flow cytometry analysis. In vitro cytotoxicity assay further confirmed their lytic activity against NK cell-resistant, EpCAM-positive cancer cells, but not to EpCAM-positive normal cells, demonstrating the retained tolerability of the CAR-iNK cells towards normal cells. Conclusion: Looking ahead, the modified iPSCs generated in the current study hold a great potential as a practically unlimited source to generate anti-EpCAM CAR iNK cells. © 2021, The Author(s).
Source Title: Stem Cell Research and Therapy
URI: https://scholarbank.nus.edu.sg/handle/10635/233532
ISSN: 1757-6512
DOI: 10.1186/s13287-021-02648-4
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_s13287-021-02648-4.pdf2.68 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

1
checked on Nov 25, 2022

Page view(s)

12
checked on Dec 1, 2022

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons